CleanSpace Holdings Limited (CSX.AX)
AUD 0.4
(-2.44%)
AUD 0.4
(-2.44%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 15.72 Million AUD | 30.01% |
| 2023 | 12.09 Million AUD | -9.47% |
| 2022 | 13.35 Million AUD | -73.24% |
| 2021 | 49.92 Million AUD | 75.76% |
| 2020 | 28.4 Million AUD | 153.13% |
| 2019 | 11.22 Million AUD | 45.29% |
| 2018 | 7.72 Million AUD | 61.42% |
| 2017 | 4.78 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 4.21 Million AUD | 0.0% |
| 2024 Q1 | 3.64 Million AUD | -42.75% |
| 2024 FY | 15.72 Million AUD | 30.01% |
| 2024 Q2 | 7.29 Million AUD | 100.0% |
| 2024 Q3 | 4.21 Million AUD | -42.2% |
| 2023 Q4 | 6.36 Million AUD | 100.0% |
| 2023 FY | 12.09 Million AUD | -9.47% |
| 2023 Q3 | 3.18 Million AUD | -44.36% |
| 2023 Q2 | 5.72 Million AUD | 100.0% |
| 2023 Q1 | 2.86 Million AUD | -54.71% |
| 2022 Q4 | 6.31 Million AUD | 100.0% |
| 2022 Q1 | 3.51 Million AUD | -65.59% |
| 2022 FY | 13.35 Million AUD | -73.24% |
| 2022 Q3 | 3.15 Million AUD | -55.11% |
| 2022 Q2 | 7.03 Million AUD | 100.0% |
| 2021 Q1 | 19.84 Million AUD | -6.09% |
| 2021 Q4 | 10.22 Million AUD | 100.0% |
| 2021 Q3 | 5.11 Million AUD | -87.12% |
| 2021 Q2 | 39.69 Million AUD | 100.0% |
| 2021 FY | 49.92 Million AUD | 75.76% |
| 2020 Q4 | 21.13 Million AUD | 99.95% |
| 2020 Q2 | 7.26 Million AUD | 100.0% |
| 2020 FY | 28.4 Million AUD | 153.13% |
| 2020 Q1 | 3.63 Million AUD | 0.0% |
| 2020 Q3 | 10.57 Million AUD | 45.55% |
| 2019 FY | 11.22 Million AUD | 45.29% |
| 2018 FY | 7.72 Million AUD | 61.42% |
| 2017 FY | 4.78 Million AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -318.77% |
| Adherium Limited | 840.98 Thousand AUD | -1769.446% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 75.186% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -284.72% |
| Anteris Technologies Ltd | 4.11 Million AUD | -282.423% |
| Control Bionics Limited | 5.12 Million AUD | -206.651% |
| CardieX Limited | 10.9 Million AUD | -44.161% |
| Compumedics Limited | 49.71 Million AUD | 68.379% |
| Cochlear Limited | 2.25 Billion AUD | 99.304% |
| Cyclopharm Limited | 27.13 Million AUD | 42.071% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | -40.132% |
| Nova Eye Medical Limited | 23.32 Million AUD | 32.597% |
| HeraMED Limited | 402.89 Thousand AUD | -3802.164% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -2454.015% |
| ImpediMed Limited | 10.31 Million AUD | -52.357% |
| InhaleRx Limited | 1.2 Million AUD | -1205.739% |
| LBT Innovations Limited | 1.25 Million AUD | -1151.728% |
| Micro-X Limited | 15.22 Million AUD | -3.283% |
| Neurotech International Limited | 1963.00 AUD | -800801.732% |
| OncoSil Medical Limited | 1.56 Million AUD | -904.336% |
| PolyNovo Limited | 103.19 Million AUD | 84.765% |
| Respiri Limited | 456.91 Thousand AUD | -3340.845% |
| SomnoMed Limited | 91.65 Million AUD | 82.846% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -137.028% |
| Uscom Limited | 3.72 Million AUD | -321.85% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | -81.334% |